Systemic administration of anti-CD20 indirectly reduces B cells in the inflamed meninges in a chronic model of central nervous system autoimmunity

被引：0
|
作者：
Kerfoot, Steven [1 ]
Tesfagiorgis, Yodit [1 ]
Kemal, Eden A. [1 ]
Craig, Heather C. [1 ]
Parham, Kate A. [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
10.4049/jimmunol.210.Supp.85.05
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Secondary organizing pneumonia associated to COVID-19 infection in patients with central nervous system inflammatory demyelinating diseases treated with anti-CD20 therapies
    Carvajal, Rene
    Rodriguez, Breogan
    Garcia-Vasco, Lorena
    Zabalza, Ana
    Arino, Helena
    Bollo, Luca
    Cabello-Clotet, Noemi
    Castillo-Justribo, Joaquin
    Cobo Calvo, Alvaro
    Comabella, Manuel
    Falco-Roget, Anna
    Galan, Ingrid
    Sarreon, Alexis
    Gomez-Estevez, Irene
    Granados, Galo
    La Puma, Delon
    Mato-Chain, Gloria
    Midaglia, Luciana
    Nieto-Garcia, Asuncion
    Otero-Romero, Susana
    Pappolla, Agustin
    Rodriguez-Barranco, Marta
    Rio, Jordi
    Tagliani, Paula
    Tur, Carmen
    Vidal-Jordana, Angela
    Vilaseca, Andreu
    Vllar, Ana
    Sastre-Garriga, Jaume
    Oreja-Guevara, Celia
    Tintore, Mar
    Montalban, Xavier
    Arrambide, Georgina
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1039 - 1040
  • [32] A pilot study of rituximab (anti-CD20) for refractory systemic lupus erythematosus: Relevance of quantity and quality reduction of B cells to clinical efficacy.
    Tanaka, Y
    Tokunaga, M
    Fujii, K
    Nawata, M
    Tsujimura, S
    Nakayamada, S
    Saito, K
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S414 - S414
  • [33] Administration of adenovirus encoding anti-CD20 antibody gene induces B-cell deletion and alleviates lupus in the BWF1 mouse model
    Wang, Chao
    Wang, Mian
    Liu, Yuan
    Zeng, Ping
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2011, 11 (06) : 693 - 697
  • [34] Expanded CD23+/CD21hi B Cells in Inflamed Lymph Nodes Are Associated with the Onset of Inflammatory-Erosive Arthritis in TNF-Transgenic Mice and Are Targets of Anti-CD20 Therapy
    Li, Jie
    Kuzin, Igor
    Moshkani, Safiehkhatoon
    Proulx, Steven T.
    Xing, Lianping
    Skrombolas, Denise
    Dunn, Robert
    Sanz, Inaki
    Schwarz, Edward M.
    Bottaro, Andrea
    JOURNAL OF IMMUNOLOGY, 2010, 184 (11): : 6142 - 6150
  • [35] Fatal central nervous system lesions emerging during anti-CD20 monoclonal antibody therapy (rituximab) for a post transplantation Epstein Barr virus-linked lymphoma
    Sirvent-von Bueltzingsloewen, A
    Sirvent, N
    Morand, P
    Cassuto, JP
    MEDICAL AND PEDIATRIC ONCOLOGY, 2003, 40 (06): : 408 - 409
  • [36] Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis
    Tacke, Sabine
    Chunder, Rittika
    Schropp, Verena
    Urich, Eduard
    Kuerten, Stefanie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (06)
  • [37] Sintilimab (anti-PD-1 antibody) combined with high-dose methotrexate, temozolomide, and rituximab (anti-CD20 antibody) in primary central nervous system lymphoma: a phase 2 study
    Zeng, Zhiyong
    Yang, Apeng
    Yang, Jingke
    Zhang, Sheng
    Xing, Zhen
    Wang, Xingfu
    Mei, Wenzhong
    Jiang, Changzhen
    Lin, Junfang
    Wu, Xiyue
    Xue, Yihui
    Wu, Zanyi
    Yu, Lianghong
    Wang, Dengliang
    Chen, Jianwu
    Zheng, Shufa
    Lin, Qiaoxian
    Chen, Qingjiao
    Dong, Jinfeng
    Zheng, Xiaoqiang
    Wang, Jizhen
    Huang, Jinlong
    Chen, Zhenying
    Chen, Ping
    Zheng, Meihong
    Zhou, Xiaofang
    He, Youwen
    Lin, Yuanxiang
    Chen, Junmin
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [38] Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
    Micha Simon
    Rojda Ipek
    György A. Homola
    Damiano M. Rovituso
    Andrea Schampel
    Christoph Kleinschnitz
    Stefanie Kuerten
    Journal of Neuroinflammation, 15
  • [39] Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
    Simon, Micha
    Ipek, Rojda
    Homola, Gyoergy A.
    Rovituso, Damiano M.
    Schampel, Andrea
    Kleinschnitz, Christoph
    Kuerten, Stefanie
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [40] The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model
    Jagessar, S. Anwar
    Fagrouch, Zahra
    Heijmans, Nicole
    Bauer, Jan
    Laman, Jon D.
    Oh, Luke
    Migone, Thi
    Verschoor, Ernst J.
    't Hart, Bert A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (03) : 727 - 738
12345